 |
Sorafenib |
|---|---|
| Trade Name | Nexavar |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2006-09-29 00:00:00 |
| Sponsor | Bayer Pharmaceuticals Corp.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981 |
| |
Sorafenib |
|---|---|
| Trade Name | Nexavar |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2006-09-29 00:00:00 |
| Sponsor | Bayer Pharmaceuticals Corp.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981 |